N'-{5-[(2E)-3-(dimethylamino)-2-propenoyl]-4-methyl-1,3-thiazol-2-yl}-N,N-dimethylimidoformamide, 95.0%, 5g

[2-(7H-pyrrolo[2,3-b]pyridin-7-yl)ethyl]amine dihydrochloride, 95.0%, 500mg

1-(2-Bromo-2-methylpropyl)-4-fluorobenzene, 95%, 250mg

5-Chloro-3-fluoro-2-iodopyridine, 95.0%, 100mg

6-Chloro-3-fluoro-2-iodopyridine, 95.0%, 250mg

tert-Butyl ((2-chloropyrimidin-5-yl)methyl)carbamate, 98%, 5g

25-Iodo-2,5,8,11,14,17,20,23-octaoxapentacosane, 95%, 1g

4-Fluoro-N-(piperidine-4-yl)benzamide hydrochloride, 95.0%, 1g

2-Chloromethyl-3-methoxy-pyrazine, 1g

Ácido 3-metoxisalicílico, mínimo 97 %, para síntesis, 5 g, envase de vidrio

1-(4-Bromophenyl)-2,2,2-trifluoroethanol, 95.0%, 5g

(METHYLSULFONIMIDOYL)BENZENE, 95%, 1g

6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide (Lornoxicam), 97.0%, 250mg